3 Warning Signs for Cannabis Investors

Is now the time to buy Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ)? Here are three headwinds that may make you reconsider.

Red siren flashing

Image source: Getty Images.

Boy, what a year 2019 was for investors in Canada’s new cannabis industry. The mood among many has certainly shifted, and the euphoria with which companies were gobbling each other up has abated. Horizons Marijuana Life Sciences Index ETF is now down 65% from its 52-week high in early 2019 (not its overall peak).

Questions about where the bottom is remain, and with cannabis stocks continuing to slide with seemingly no end in sight, investors remain cautious with respect to these names, and deservedly so.

Here are three of the biggest question marks, or warning signs, if you will, that investors need to keep an eye on in 2019 when considering if/when to jump back into the fray.

Inventory levels

I’ve pointed to this in the past — there’s a glut of inventory out there, and it’s killing margins. Companies are being forced to destroy product; cannabis is a natural product, and has a shelf life. It’s also a commodity, and supply and demand is a real thing that drives prices.

With provincial distributors the main customers of most cannabis producers, the “price taker” reality for producers is starting to kick in (and it appears investors are starting to notice this issue).

As of mid-2019, the glut was approximated at 150,000 kg of the green stuff — a truly staggering sum.

Black market is alive and strong

The black market is unregulated.

This fact alone is enough to make anyone understand the disadvantage any large-scale licensed cannabis producer has when competing against some guys growing plants in their basement. I’ve gone into detail about a few of the key hurdles producers face and given readers a taste of some of the red tape cannabis producers have to fight through to get their product to market.

You can bet the Canadian government will want to take bigger and bigger tax bites out of the profit pie that producers are able to consume most of right now. As margins shrink and taxes rise, expect to see profit expectations continue to drop, hurting share prices further. I still do not believe the true impact of future taxation and over-regulation are built into these producers’ share prices.

Cannabis retail is failing consumers

Having cannabis packaged in a similar fashion to cigarettes is killing the retail experience. Having product at government stores locked behind an opaque cabinet, with consumers having to guess what they are going to get, is mind boggling.

The retail experience at most government stores across the country is lacking. The guy on the street corner has the advantage at this stage in the game, and while the government talks a big talk about getting rid of the black market across the country, the abysmal way in which cannabis is retailed at this point in time is likely to lead to continued problems with black market penetration in 2020 and beyond.

Ontario has realized this issue, and there are seemingly plans to privatize retail in that province; questions remain, however, as to what regulations will be put in place for these retailers (if they’re held to the same standards as government stores, it won’t help). The one hope for cannabis investors is that private stores will roll out quicker, as this has been another major pain point for the industry — the true lack of physical retail locations, again, due mostly to government regulation.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »